National Institute on Drug Abuse; Notice of Closed Meetings, 24637 [2021-09743]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 87 / Friday, May 7, 2021 / Notices
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: PORTER NEUROSCIENCE
RESEARCH CENTER, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual
Meeting).
Time: June 2, 2021, 11:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: PORTER NEUROSCIENCE
RESEARCH CENTER, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual
Meeting).
Time: June 3, 2021, 2:20 p.m. to 6:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: PORTER NEUROSCIENCE
RESEARCH CENTER, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jennifer E Mehren, Ph.D.,
Scientific Advisor, Division of Intramural
Research Programs, National Institute of
Mental Health, NIH, 35A Convent Drive,
Room GE 412, Bethesda, MD 20892–3747,
301–496–3501, mehrenj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: May 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09745 Filed 5–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Digital
Technologies to Address the Social
Determinants of Health in Context of
Substance Use Disorders (SUD) (R41/R42/
R43/R44).
Date: June 4, 2021.
VerDate Sep<11>2014
19:55 May 06, 2021
Jkt 253001
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Trinh T. Tran, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5843, trinh.tran@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Novel
Approaches to Decrease Stigma of Substance
Use Disorders in order to Facilitate
Prevention, Treatment, and Support During
Recovery (R41/R42/R43/R44).
Date: June 7, 2021.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Trinh T. Tran, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5843, trinh.tran@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
America’s Startups and Small Businesses
Build Technologies to Stop the Opioid
Epidemic (R43/R44/R41/R42—Clinical Trial
Optional).
Date: June 17–18, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 827–5819, gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Career Development and Education SEP
(K99/R00 and R25).
Date: June 29–30, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
on Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5702, sindhu.kizhakkemadathil@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
24637
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: May 4, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09743 Filed 5–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket Number USCG–2021–0183]
Modernization of Coast Guard Base
Seattle; Preparation of Programmatic
Environmental Impact Statement
Coast Guard, DHS.
Notice of intent to prepare a
Programmatic Environmental Impact
Statement; notice of virtual scoping; and
request for comments.
AGENCY:
ACTION:
The United States Coast
Guard, as the lead agency, announces its
intent to prepare a Programmatic
Environmental Impact Statement (PEIS).
The PEIS will evaluate the potential
environmental consequences of the
Coast Guard’s Proposed Action to
expand and modernize Coast Guard
Base Seattle in Seattle, Washington.
Notice is hereby given that the public
scoping process has begun for the
preparation of a PEIS for the Proposed
Action. The purpose of the scoping
process is to solicit public comments
regarding the range of issues,
information, and analyses relevant to
the Proposed Action, including
potential environmental impacts and
reasonable alternatives to address in the
PEIS. This PEIS is being prepared in
compliance with the National
Environmental Policy Act (NEPA) of
1969 and the regulations implemented
by the Council on Environmental
Quality. The Coast Guard has
determined that a PEIS is the most
appropriate type of NEPA document for
this action because the Proposed Action
is anticipated to occur over several
years, and many of the site-specific
project details are not known. This
notice also notifies the public that the
Coast Guard intends to host a webbased, web-based project site to provide
additional information to the public and
to solicit comments on potential issues,
concerns, and reasonable alternatives
that should be considered in the PEIS.
SUMMARY:
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 86, Number 87 (Friday, May 7, 2021)]
[Notices]
[Page 24637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09743]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Digital Technologies to Address the Social
Determinants of Health in Context of Substance Use Disorders (SUD)
(R41/R42/R43/R44).
Date: June 4, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review, Division of Extramural
Research, National Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5843,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Novel Approaches to Decrease Stigma of Substance Use
Disorders in order to Facilitate Prevention, Treatment, and Support
During Recovery (R41/R42/R43/R44).
Date: June 7, 2021.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer,
Office of Extramural Policy and Review, Division of Extramural
Research, National Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5843,
[email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; America's Startups and Small Businesses Build
Technologies to Stop the Opioid Epidemic (R43/R44/R41/R42--Clinical
Trial Optional).
Date: June 17-18, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 827-5819, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Career Development and Education SEP (K99/R00
and R25).
Date: June 29-30, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Scientific Review Branch, National Institute on Drug
Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD
20892, (301) 827-5702, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 4, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-09743 Filed 5-6-21; 8:45 am]
BILLING CODE 4140-01-P
